Citigroup faces scrutiny after an $81 trillion error and fluctuating analyst ratings for stocks like Abbott Labs, Bio-Techne, Thermo Fisher, Mettler-Toledo, and Okta. Read more...

Citigroup has been actively adjusting price targets and initiating coverage across various sectors, impacting companies like Bio-Techne, Hologic, and Titan America. Here's a quick rundown. Read more...

Mutual of America Capital Management LLC has adjusted its holdings in several biotech and tech companies, including Cytokinetics, Lumentum Holdings, and Bio-Techne Co., according to recent SEC filings. StockNews.com also upgraded Acacia Research. Read more...